the checkmate 9la trial for stage iv/recurrent non-small cell lung cancer
Published 4 years ago • 833 plays • Length 10:46Download video MP4
Download video MP3
Similar videos
-
10:46
the checkmate 9la trial for stage iv/recurrent non-small cell lung cancer
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc
-
1:22
dr. reck on safety data from the checkmate-9la trial in metastatic/recurrent nsclc
-
5:43
checkmate 9la trial on nivolumab plus ipilimumab for nsclc
-
2:28
perspectives on the checkmate 9la study
-
8:03
checkmate-9la: histology and frontline impact
-
7:16
checkmate 9la study: nivo ipi in nsclc
-
6:31
recent combination approval: checkmate-9la regimen
-
2:08
dr. porter on the 3-year follow-up data from the checkmate-9la trial in nsclc
-
17:08
three-year update from the checkmate 227 clinical trial for advanced nsclc
-
3:30
checkmate 9la: tmb and immune checkpoint inhibitor efficacy
-
4:05
checkmate 9la: first-line nivolumab ipilimumab 2 cycles chemotherapy vs 4 cycles chemo in an...
-
4:51
clinical trial for stage iv lung cancer (nsclc): btcrc-lun17-139
-
10:12
nivolumab ipilimumab 2 cycles of platinum-doublet chemo vs 4 cycles chemo for stage iv nsclc
-
3:24
ipi/nivo in metastatic nsclc
-
6:07
interpreting the results of checkmate-227 in nsclc
-
3:04
nsclc highlights at asco 2020
-
1:18
dr. reck on the safety of pembrolizumab in keynote-024 in metastatic nsclc
-
2:01
upcoming nsclc trials in 2022: checkmate 816 & keynote-091